Company / Total Assets
Tandem Diabetes Care Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$881.1M
FY2025
5-year range
$881.1M / $1.1B
FY2021-FY2025
Trend
-8.9%
vs FY2024
Sector context
#120 of 161
Health Care
What the data says
Tandem Diabetes Care's total assets of $881M is lower than 75% of companies in the Health Care sector (FY2025). Total Assets has fluctuated over the past 10 years, ranging from $95M in FY2017 to $1.1B in FY2022.
Based on SEC 10-K filings.
$881M in FY2025 with a 5-year CAGR of +4.2%.
Declined from $953M to $881M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -5.8%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 161This company $881.1M Sector average $14.8B
▼
-94.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.2%, indicating consistent growth.
- In FY2025, total assets decreased 8.9% year-over-year.
- Ranks #120 out of 161 companies in the Health Care sector.
- Peak total assets was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $881.1M | -8.9% |
| FY2024 | $967.7M | +1.6% |
| FY2023 | $952.7M | -9.5% |
| FY2022 | $1.1B | +16.3% |
| FY2021 | $905.1M | +26.3% |
| FY2020 | $716.4M | +119.7% |
| FY2019 | $326.1M | +58.1% |
| FY2018 | $206.3M | +116.4% |
| FY2017 | $95.3M | -15.2% |
| FY2016 | $112.4M | -9.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026